Abstract

Simple SummaryRadiotherapy is an important part of the multimodality approach to treating malignant pleural mesothelioma. In recent studies there is a new trend to treat patients with intact lungs instead of following surgery. This treatment creates significant concerns regarding lung toxicity. We describe two methods to reduce that toxicity. One is the use of constant pulmonary airway pressure (CPAP) to inflate the lungs during treatment. The second is utilizing a novel method of planning and delivering radiotherapy called volumetric modulated arc therapy (VMAT).Malignant pleural mesothelioma (MPM) is a deadly disease and radiotherapy (RT) plays an important role in its management. Recent developments in technique have made it is possible to deliver RT to MPM in the intact lung. However, it is imperative to reduce normal lung doses. We present a pilot study examining the use of CPAP and VMAT radiotherapy to reduce toxicity when treating MPM, involving three consecutive patients with MPM, not amenable to surgery, who were treated according to Helsinki committee approval. Patients were simulated using four-dimentional CT simulation with the assistance of CPAP lung inflation, then were treated using both IMRT and VMAT techniques. Radiation lung dose was optimized based on accepted lung dose constraints. Patients were followed for toxicity as well as local control and survival. Results: Three patients were treated with CPAP-based IMRT treatment. These patients tolerated the treatment and DVH constraints were able to be met. The comparison plans among the four VMAT arcs and the IMRT static field treatment were able to accomplish the treatment planning objectives without significant advantages with either technique. The treatment combined with CPAP reduced the normal lung dose in MPM patients with intact lungs. This technique is worthy of further investigation.

Highlights

  • Malignant pleural mesothelioma (MPM) is a rare and aggressive thoracic malignancy with an established association with occupational or environmental asbestos exposure.About 3000 new cases are diagnosed each year in the US [1]

  • We summarize our experience with utilizing Continuous positive airway pressure (CPAP) in the definitive treatment of unresectable or inoperable MPM patients in combination with modern radiotherapy techniques

  • Before being referred for definitive radiotherapy, all cases were discussed in a multidisciplinary team that included thoracic surgeons, pulmonologists, medical oncologists, radiation oncologists and radiologists

Read more

Summary

Introduction

About 3000 new cases are diagnosed each year in the US [1]. The management of these patients should involve an experienced multidisciplinary team [2,3]. The majority of MPM patients require more than one treatment modality. These modalities include surgery, radiation therapy (RT), and systemic chemotherapy. RT can be used as a part of multimodality treatment, as a single modality with definitive or palliative intent. Hemithoracic radiation following EPP seems feasible and may decrease local recurrence rates [4,5,6,7,8,9,10]. A neoadjuvant approached has been explored [11,12,13,14]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call